ADRM1 gene amplification is a candidate driver for metastatic gastric cancers

Predictive biomarker candidates for the response of gastric cancer to targeted and cytotoxic agents

(2014) Hark Kyun Kim et al.   PHARMACOGENOMICS

A bis-Benzylidine Piperidone Targeting Proteasome Ubiquitin Receptor RPN13/ADRM1 as a Therapy for Cancer

(2013) Ravi K. Anchoori et al.   CANCER CELL

Identification of genes with a correlation between copy number and expression in gastric cancer

(2012) Lei Cheng et al.   BMC Medical Genomics

Integration of DNA Copy Number Alterations and Transcriptional Expression Analysis in Human Gastric Cancer

(2012) Biao Fan et al.   PLoS One

A Gene Expression Signature of Acquired Chemoresistance to Cisplatin and Fluorouracil Combination Chemotherapy in Gastric Cancer Patients

(2011) Hark Kyun Kim et al.   PLoS One

Amplification of the 20q Chromosomal Arm Occurs Early in Tumorigenic Transformation and May Initiate Cancer

(2011) Yuval Tabach et al.   PLoS One

Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy

(2010) H K Kim et al.   PHARMACOGENOMICS JOURNAL

Epidermal Growth Factor Receptor Activation Protects Gastric Epithelial Cells From Helicobacter pylori-Induced Apoptosis

(2009) Fang Yan et al.   GASTROENTEROLOGY

Comprehensive analysis of 20q13 genes in ovarian cancer identifiesADRM1as amplification target

(2008) Marlena S. Fejzo et al.   GENES CHROMOSOMES & CANCER

Ubiquitin docking at the proteasome through a novel pleckstrin-homology domain interaction

(2008) Patrick Schreiner et al.   NATURE

Proteasome subunit Rpn13 is a novel ubiquitin receptor

(2008) Koraljka Husnjak et al.   NATURE